세계의 항핵항체(ANA) 검사 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Antibody Antinuclear Test Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

US $ 4,995 ￦ 6,838,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 9,987,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,630,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 전 세계 항핵항체(ANA) 검사 시장에 대한 종합적인 조사 보고서를 발표하여 원동력, 새로운 동향, 기회, 과제 등 주요 시장 역학에 대한 상세한 분석을 제공했습니다.

주요 인사이트

• 항핵항체검사 시장 규모(2025년) : 27억260만 달러
• 예측 시장 규모(2032년) : 65억 3,850만 달러
• 세계 시장 성장률(CAGR 2025-2032년) : 13.5%

항핵항체(ANA) 검사 시장 : 조사 범위

항핵항체(ANA) 검사 시장은 체내 세포를 표적으로 하는 혈액 중의 자가항체의 검출을 목적으로 한 진단 솔루션으로 구성되어 있습니다. 글렌 증후군과 같은 자가면역질환의 진단에 사용됩니다.

시장 성장 촉진요인 :

항핵항체검사 세계 시장은 자가면역질환의 세계의 이환율의 대폭적인 상승으로, 강력한 성장을 이루고 있습니다. 진단 방법론의 기술 발전, 예를 들어 전통적인 기법에서 보다 정확하고 효율적인 다중 분석 및 ELISA로의 전환은 테스트 신뢰성과 처리량을 향상시키고 있습니다. 게다가 자가면역 질환에 더 취약한 노인 인구의 증가와 병원 및 실험실의 일상적인 검사 프로토콜에 ANA 검사를 통합함으로써 시장 확장이 더욱 촉진되고 있습니다.

시장 성장 억제요인 :

유망한 전망과는 달리, 이 시장은 그 가능성을 충분히 발휘하는 것을 방해하는 과제에 직면하고 있습니다. 숙련된 전문가의 부족과 사용하는 방법에 의한 검사 결과의 편차는 진단 정밀도를 제한할 수 있으며, 새로운 진단 도구의 승인에 관한 규제상의 장애물과 일관된 임상 검증의 필요성도 시장 성장의 제약 요인이 되고 있습니다.

시장 기회 :

항핵항체(ANA) 검사 시장은 특히 건강 관리의 인프라가 급속히 개선되고 있는 신흥국에서 큰 비즈니스 기회를 가져오고 있습니다. 감도 진단 플랫폼을 구축하기 위한 연구개발에 대한 투자는 혁신의 새로운 프론티어를 엽니다.

이 보고서에서 다루는 주요 질문

• 세계의 항핵항체(ANA) 검사 시장의 성장을 가속하는 주요 요인은?
• ANA 검사 수요가 가장 높은 지역과 시장 부문은 어디인가?
• 진단 기술의 혁신은 어떻게 시장 동향을 형성하고 있는가?
• ANA 검사 시장의 주요 기업은 어딘가, 또 어떤 전략을 채택하고 있는가?
• 세계의 ANA 검사 시장의 새로운 동향과 예측은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장의 범위와 정의
• 시장 역학
  • 성장 촉진요인
  • 억제요인
  • 기회
  • 주요 동향
• 거시경제 요인
  • 신흥국의 헬스케어 인프라 개발
  • 헬스케어의 디지털 전환과 데이터 통합
• COVID-19의 영향 분석
• 예측 요인- 관련성과 영향

제3장 부가가치가 있는 통찰

• 제품 수요 분석
• 규제 상황
• 밸류체인 분석
• PESTLE 분석
• Porter's Five Forces 분석

제4장 세계의 항핵항체(ANA) 검사 시장 전망

• 주요 하이라이트
  • 시장 규모 예측
  • 시장 규모와 전년대비 성장률
  • 절대 수익 기회
• 시장 규모와 수량 분석 및 예측
  • 과거 시장 규모 분석, 2019-2024년
  • 현재 시장 규모 분석과 예측, 2025-2032년
• 세계의 항핵항체(ANA) 검사 시장 전망:제품
  • 소개/주요 조사 결과
  • 과거 시장 규모와 수량 분석, 제품별, 2019-2024년
  • 현재 시장 규모와 수량의 분석과 예측, 제품별, 2025-2032년
    • 시약 및 분석 키트
    • 시스템
    • 소프트웨어 및 서비스
  • 시장 매력 분석 : 제품
• 세계의 항핵항체(ANA) 검사 시장 전망 : 기술
  • 소개/주요 조사 결과
  • 과거 시장 규모 분석, 기술별, 2019-2024년
  • 현재 시장 규모 분석과 예측, 기술별, 2025-2032년
    • ELISA
    • 면역형광 검정
    • 멀티플렉스 분석
  • 시장 매력 분석 : 기술
• 세계의 항핵항체(ANA) 검사 시장 전망 : 용도
  • 소개/주요 조사 결과
  • 과거 시장 규모 분석, 용도별, 2019-2024년
  • 현재 시장 규모 분석과 예측, 용도별, 2025-2032년
    • 류마티스 관절
    • 전신성 홍반성 루푸스
    • 셰그렌 증후군
    • 피부경화증
    • 기타
  • 시장 매력 분석 : 용도
• 세계의 항핵항체(ANA) 검사 시장 전망 : 최종 용도
  • 소개/주요 조사 결과
  • 과거 시장 규모 분석, 최종 용도별, 2019-2024년
  • 현재 시장 규모 분석과 예측, 최종 용도별, 2025-2032년
    • 병원
    • 임상 실험실
    • 의사의 사무실 실험실
    • 기타
  • 시장 매력 분석 : 최종 용도

제5장 세계의 항핵항체(ANA) 검사 시장 전망 : 지역

• 주요 하이라이트
• 과거 시장 규모와 수량 분석, 지역별, 2019-2024년
• 현재 시장 규모와 수량의 분석과 예측, 지역별, 2025-2032년
  • 북미
  • 유럽
  • 동아시아
  • 남아시아와 오세아니아
  • 라틴아메리카
  • 중동 및 아프리카
• 시장 매력 분석 :지역

제6장 북미의 항핵항체(ANA) 검사 시장 전망

제7장 유럽의 항핵항체(ANA) 검사 시장 전망

제8장 동아시아의 항핵항체(ANA) 검사 시장 전망

제9장 남아시아 및 오세아니아의 항핵항체(ANA) 검사 시장 전망

제10장 라틴아메리카의 항핵항체(ANA) 검사 시장 전망

제11장 중동 및 아프리카의 항핵항체(ANA) 검사 시장 전망

제12장 경쟁 구도

• 시장 점유율 분석, 2025년
• 시장 구조
  • 시장별 경쟁 강도 매핑
  • 경쟁 대시보드
• 엔터프라이즈 프로파일(상세 - 개요, 재무, 전략, 최근 동향)
  • Trinity Biotech Plc.
  • ERBA Diagnostics Mannheim GmbH
  • Antibodies Incorporated
  • Inova Diagnostics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • ZEUS Scientific, Inc.
  • Immuno Concepts NA Ltd.
  • EUROIMMUN Medizinische Labordiagnostika AG
  • Alere Inc.
  • Others

제13장 부록

• 조사 방법
• 조사의 전제
• 두자어 및 약어

SHW

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global Antinuclear Antibody (ANA) Test Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• Antinuclear Antibody Test Market Size (2025E): US$ 2,702.6 Mn
• Projected Market Value (2032F): US$ 6,538.5 Mn
• Global Market Growth Rate (CAGR 2025 to 2032): 13.5%

Antinuclear Antibody Test Market - Report Scope:

The antinuclear antibody (ANA) test market comprises diagnostic solutions aimed at detecting autoantibodies in blood that target the body's own cells. These tests are primarily used for diagnosing autoimmune disorders, such as lupus, rheumatoid arthritis, and Sjogren's syndrome. The increasing prevalence of autoimmune diseases, coupled with advancements in diagnostic technologies and growing awareness about early disease detection, is propelling market growth.

Market Growth Drivers:

The global antinuclear antibody test market is witnessing strong growth due to a significant rise in the incidence of autoimmune diseases globally. Increased healthcare spending and heightened awareness among patients regarding early diagnosis of chronic diseases are further driving demand for ANA tests. Technological advancements in diagnostic methodologies, such as the shift from traditional techniques to more accurate and efficient multiplex assays and ELISA, are enhancing test reliability and throughput. Moreover, rising geriatric populations, who are more susceptible to autoimmune conditions, and the integration of ANA testing into routine screening protocols in hospitals and labs are further boosting market expansion.

Market Restraints:

Despite the promising outlook, the market faces challenges that may impede its full potential. High costs associated with advanced ANA testing systems, especially in developing economies, can act as a deterrent to widespread adoption. Additionally, lack of skilled professionals for interpreting complex test results and variability in test outcomes depending on the technique used can limit diagnostic accuracy. Regulatory hurdles for approval of new diagnostic tools and the need for consistent clinical validation also pose constraints to market growth.

Market Opportunities:

The antinuclear antibody test market presents robust opportunities, particularly in emerging economies where healthcare infrastructure is improving rapidly. The increasing focus on personalized medicine and early-stage disease detection offers avenues for expanding test applications beyond traditional autoimmune conditions. Investments in research and development to create cost-effective, high-sensitivity diagnostic platforms open new frontiers for innovation. Collaborations between diagnostics manufacturers and healthcare providers, as well as integration of digital health technologies, such as AI-based test interpretation, provide a competitive edge for companies looking to tap into untapped markets.

Key Questions Answered in the Report:

• What are the primary factors driving the global antinuclear antibody test market's growth?
• Which regions and market segments are experiencing the highest demand for ANA testing?
• How are innovations in diagnostic technologies shaping market trends?
• Who are the leading players in the ANA test market and what strategies are they employing?
• What are the emerging trends and projections for the global ANA test market?

Competitive Intelligence and Business Strategy:

Leading companies in the global antinuclear antibody test market, such as Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Inova Diagnostics, Inc., and EUROIMMUN Medizinische Labordiagnostika AG, are actively investing in research, automation, and global expansion strategies. These players are focusing on developing next-generation ANA test kits with improved specificity and ease of use. Strategic collaborations, product launches, and mergers & acquisitions are common strategies to strengthen market presence. Companies are also expanding their diagnostic portfolios by integrating software and digital solutions for better data analysis and workflow efficiency.

Companies Covered in This Report:

• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• Inova Diagnostics, Inc.
• EUROIMMUN Medizinische Labordiagnostika AG
• Alere Inc.
• ZEUS Scientific, Inc.
• Trinity Biotech Plc.
• ERBA Diagnostics Mannheim GmbH
• Antibodies Incorporated
• Immuno Concepts NA Ltd.

Market Segmentation

By Product:

• Reagents and Assay Kits
• Systems
• Software and Services

By Technique:

• ELISA
• Immunofluorescence Assay
• Multiplex Assay

By Application:

• Rheumatoid Arthritis
• Systemic Lupus Erythematosus
• Sjogren's Syndrome
• Scleroderma
• Others

By End-use:

• Hospitals
• Clinical Laboratories
• Physician Office Laboratories
• Others

By Region:

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Antinuclear Antibody Test Market Snapshot, 2025 and 2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Key Trends
• 2.3. Macro-economic Factors
  • 2.3.1. Healthcare Infrastructure Development in Emerging Economies
  • 2.3.2. Digital Transformation and Data Integration in Healthcare
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Product Demand Analysis
• 3.2. Regulatory Landscape
• 3.3. Value Chain Analysis
• 3.4. PESTLE Analysis
• 3.5. Porter's Five Force Analysis

4. Global Antinuclear Antibody Test Market Outlook

• 4.1. Key Highlights
  • 4.1.1. Market Volume (Units) Projections
  • 4.1.2. Market Size (US$ Mn) and Y-o-Y Growth
  • 4.1.3. Absolute $ Opportunity
• 4.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast
  • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
  • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
• 4.3. Global Antinuclear Antibody Test Market Outlook: Product
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
  • 4.3.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 4.3.3.1. Reagents and Assay Kits
    • 4.3.3.2. Systems
    • 4.3.3.3. Software and Services
  • 4.3.4. Market Attractiveness Analysis: Product
• 4.4. Global Antinuclear Antibody Test Market Outlook: Technique
  • 4.4.1. Introduction / Key Findings
  • 4.4.2. Historical Market Size (US$ Mn) Analysis, By Technique, 2019-2024
  • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
    • 4.4.3.1. ELISA
    • 4.4.3.2. Immunofluorescence Assay
    • 4.4.3.3. Multiplex Assay
  • 4.4.4. Market Attractiveness Analysis: Technique
• 4.5. Global Antinuclear Antibody Test Market Outlook: Application
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
  • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 4.5.3.1. Rheumatoid Arthritis
    • 4.5.3.2. Systemic Lupus Erythematosus
    • 4.5.3.3. Sjogren's Syndrome
    • 4.5.3.4. Scleroderma
    • 4.5.3.5. Others
  • 4.5.4. Market Attractiveness Analysis: Application
• 4.6. Global Antinuclear Antibody Test Market Outlook: End Use
  • 4.6.1. Introduction / Key Findings
  • 4.6.2. Historical Market Size (US$ Mn) Analysis, By End Use, 2019-2024
  • 4.6.3. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
    • 4.6.3.1. Hospitals
    • 4.6.3.2. Clinical Laboratories
    • 4.6.3.3. Physician Office Laboratories
    • 4.6.3.4. Others
  • 4.6.4. Market Attractiveness Analysis: End Use

5. Global Antinuclear Antibody Test Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019-2024
• 5.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America Antinuclear Antibody Test Market Outlook

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 6.2.1. By Country
  • 6.2.2. By Product
  • 6.2.3. By Technique
  • 6.2.4. By Application
  • 6.2.5. By End Use
• 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 6.4.1.
    • 6.4.1.1.
      • 6.4.1.1.1. Reagents and Assay Kits
      • 6.4.1.1.2. Systems
      • 6.4.1.1.3. Software and Services
• 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
  • 6.5.1. ELISA
  • 6.5.2. Immunofluorescence Assay
  • 6.5.3. Multiplex Assay
• 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 6.6.1. Rheumatoid Arthritis
  • 6.6.2. Systemic Lupus Erythematosus
  • 6.6.3. Sjogren's Syndrome
  • 6.6.4. Scleroderma
  • 6.6.5. Others
• 6.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
  • 6.7.1. Hospitals
  • 6.7.2. Clinical Laboratories
  • 6.7.3. Physician Office Laboratories
  • 6.7.4. Others
• 6.8. Market Attractiveness Analysis

7. Europe Antinuclear Antibody Test Market Outlook

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Product
  • 7.2.3. By Technique
  • 7.2.4. By Application
  • 7.2.5. By End Use
• 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Russia
  • 7.3.7. Turkey
  • 7.3.8. Rest of Europe
• 7.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 7.4.1.
    • 7.4.1.1.
      • 7.4.1.1.1. Reagents and Assay Kits
      • 7.4.1.1.2. Systems
      • 7.4.1.1.3. Software and Services
• 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
  • 7.5.1. ELISA
  • 7.5.2. Immunofluorescence Assay
  • 7.5.3. Multiplex Assay
• 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 7.6.1. Rheumatoid Arthritis
  • 7.6.2. Systemic Lupus Erythematosus
  • 7.6.3. Sjogren's Syndrome
  • 7.6.4. Scleroderma
  • 7.6.5. Others
• 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
  • 7.7.1. Hospitals
  • 7.7.2. Clinical Laboratories
  • 7.7.3. Physician Office Laboratories
  • 7.7.4. Others
• 7.8. Market Attractiveness Analysis

8. East Asia Antinuclear Antibody Test Market Outlook

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Product
  • 8.2.3. By Technique
  • 8.2.4. By Application
  • 8.2.5. By End Use
• 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
• 8.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 8.4.1.
    • 8.4.1.1.
      • 8.4.1.1.1. Reagents and Assay Kits
      • 8.4.1.1.2. Systems
      • 8.4.1.1.3. Software and Services
• 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
  • 8.5.1. ELISA
  • 8.5.2. Immunofluorescence Assay
  • 8.5.3. Multiplex Assay
• 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 8.6.1. Rheumatoid Arthritis
  • 8.6.2. Systemic Lupus Erythematosus
  • 8.6.3. Sjogren's Syndrome
  • 8.6.4. Scleroderma
  • 8.6.5. Others
• 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
  • 8.7.1. Hospitals
  • 8.7.2. Clinical Laboratories
  • 8.7.3. Physician Office Laboratories
  • 8.7.4. Others
• 8.8. Market Attractiveness Analysis

9. South Asia & Oceania Antinuclear Antibody Test Market Outlook

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Product
  • 9.2.3. By Technique
  • 9.2.4. By Application
  • 9.2.5. By End Use
• 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. India
  • 9.3.2. Southeast Asia
  • 9.3.3. ANZ
  • 9.3.4. Rest of South Asia & Oceania
• 9.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 9.4.1.
    • 9.4.1.1.
      • 9.4.1.1.1. Reagents and Assay Kits
      • 9.4.1.1.2. Systems
      • 9.4.1.1.3. Software and Services
• 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
  • 9.5.1. ELISA
  • 9.5.2. Immunofluorescence Assay
  • 9.5.3. Multiplex Assay
• 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 9.6.1. Rheumatoid Arthritis
  • 9.6.2. Systemic Lupus Erythematosus
  • 9.6.3. Sjogren's Syndrome
  • 9.6.4. Scleroderma
  • 9.6.5. Others
• 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
  • 9.7.1. Hospitals
  • 9.7.2. Clinical Laboratories
  • 9.7.3. Physician Office Laboratories
  • 9.7.4. Others
• 9.8. Market Attractiveness Analysis

10. Latin America Antinuclear Antibody Test Market Outlook

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Product
  • 10.2.3. By Technique
  • 10.2.4. By Application
  • 10.2.5. By End Use
• 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. Brazil
  • 10.3.2. Mexico
  • 10.3.3. Rest of Latin America
• 10.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 10.4.1.
    • 10.4.1.1.
      • 10.4.1.1.1. Reagents and Assay Kits
      • 10.4.1.1.2. Systems
      • 10.4.1.1.3. Software and Services
• 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
  • 10.5.1. ELISA
  • 10.5.2. Immunofluorescence Assay
  • 10.5.3. Multiplex Assay
• 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 10.6.1. Rheumatoid Arthritis
  • 10.6.2. Systemic Lupus Erythematosus
  • 10.6.3. Sjogren's Syndrome
  • 10.6.4. Scleroderma
  • 10.6.5. Others
• 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
  • 10.7.1. Hospitals
  • 10.7.2. Clinical Laboratories
  • 10.7.3. Physician Office Laboratories
  • 10.7.4. Others
• 10.8. Market Attractiveness Analysis

11. Middle East & Africa Antinuclear Antibody Test Market Outlook

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Product
  • 11.2.3. By Technique
  • 11.2.4. By Application
  • 11.2.5. By End Use
• 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. GCC Countries
  • 11.3.2. Egypt
  • 11.3.3. South Africa
  • 11.3.4. Northern Africa
  • 11.3.5. Rest of Middle East & Africa
• 11.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 11.4.1.
    • 11.4.1.1.
      • 11.4.1.1.1. Reagents and Assay Kits
      • 11.4.1.1.2. Systems
      • 11.4.1.1.3. Software and Services
• 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
  • 11.5.1. ELISA
  • 11.5.2. Immunofluorescence Assay
  • 11.5.3. Multiplex Assay
• 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 11.6.1. Rheumatoid Arthritis
  • 11.6.2. Systemic Lupus Erythematosus
  • 11.6.3. Sjogren's Syndrome
  • 11.6.4. Scleroderma
  • 11.6.5. Others
• 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
  • 11.7.1. Hospitals
  • 11.7.2. Clinical Laboratories
  • 11.7.3. Physician Office Laboratories
  • 11.7.4. Others
• 11.8. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2025
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping By Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. Trinity Biotech Plc.
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Products
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. ERBA Diagnostics Mannheim GmbH
  • 12.3.3. Antibodies Incorporated
  • 12.3.4. Inova Diagnostics, Inc.
  • 12.3.5. Bio-Rad Laboratories, Inc.
  • 12.3.6. Thermo Fisher Scientific, Inc.
  • 12.3.7. ZEUS Scientific, Inc.
  • 12.3.8. Immuno Concepts NA Ltd.
  • 12.3.9. EUROIMMUN Medizinische Labordiagnostika AG
  • 12.3.10. Alere Inc.
  • 12.3.11. Others

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations

관련자료